...
首页> 外文期刊>Frontiers in Cell and Developmental Biology >Layer-By-Layer Fabrication of Large and Thick Human Cardiac Muscle Patch Constructs With Superior Electrophysiological Properties
【24h】

Layer-By-Layer Fabrication of Large and Thick Human Cardiac Muscle Patch Constructs With Superior Electrophysiological Properties

机译:逐层制造大型和厚的人心肌贴片构建体,具有优异的电生理特性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Engineered cardiac tissues fabricated from human induced pluripotent stem cells (hiPSCs) show promise for restoring function in infarcted left ventricular (LV) myocardium. For these constructs to reach their clinical potential, they need to be of a clinically relevant volume and thickness, and capable of generating synchronous and forceful contraction to assist the pumping action of the recipient heart. Design requirements necessitate a structure thickness sufficient to produce a useful contractile force, prevascularization to overcome diffusion limitations and sufficient structural development to allow for maximal cell communication. Previous attempts to meet these requirements have been hampered by diffusion limits of oxygen and nutrients (100-200 μm) resulting in necrotic regions. This study employs a layer-by-layer (LbL) fabrication method to produce cardiac tissue constructs that meet these design requirements and mimic normal myocardium in form and function. Thick ( 2 mm) cardiac tissues created from human induced pluripotent stem cell-derived cardiomyocytes, endothelial cells and fibroblasts were assessed, in vitro, over a 4-week period for viability ( 30 cm/s). These results demonstrate that LbL fabrication can be utilized successfully in creating prevascularized, functional cardiac tissue constructs from hiPSCs for potential therapeutic applications.
机译:由人诱导的多能干细胞(HIPSC)制造的工程心脏组织显示出在梗死的左心室(LV)心肌中的恢复功能。对于这些构建体来达到其临床潜力,他们需要具有临床相关的体积和厚度,并且能够产生同步和强力收缩,以帮助接受者心脏的泵送动作。设计要求需要具有足以产生有用的收缩力的结构厚度,克服扩散限制和足够的结构开发来允许最大细胞通信。以前的尝试通过氧气和营养素(100-200μm)的扩散限制导致坏死地区的扩散限制被阻碍了。本研究采用层逐层(LBL)制造方法,以产生满足这些设计要求的心脏组织构建体,并以形式和功能模拟正常心肌。从人诱导的多能干细胞衍生的心肌细胞,内皮细胞和成纤维细胞产生的厚(& 2 mm)心脏组织在体外进行评估,在4周的时间内进行活力(30cm / s)。这些结果表明,LBL制备可以成功地用于从源治疗应用的HIPSC产生患者的患者血糖化的功能心脏组织构建体中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号